Bradford Hill Seminar – The Cancer Loyalty Card Study (CLOCS), aiming to help reduce the delays in cancer diagnosis using transaction data

Wed 2 July

East Forvie Building

All are invited to the Bradford Hill Seminar:

The Cancer Loyalty Card Study (CLOCS), aiming to help reduce the delays in cancer diagnosis using transaction data

Professor James Flanagan, Imperial College London

Register to attend
Please note this will be a free hybrid seminar, with the option to attend in-person (Large Seminar Room, East Forvie Building, Forvie Site, Robinson Way, Cambridge CB2 0SR) or virtually (via Teams).

No registration is required to attend in person.

Register in advance to attend this seminar online at:

https://events.teams.microsoft.com/event/9d02ab32-b2e7-4bdb-9b33-ad126d573679@49a50445-bdfa-4b79-ade3-547b4f3986e9

Abstract
The first Cancer Loyalty Card Study (CLOCS) project revealed that ovarian cancer patients begin buying over-the-counter medications months before seeing a doctor, suggesting a missed opportunity for earlier diagnosis. This research opens new conversations about how everyday data might support earlier cancer detection, and what it takes for the public to feel comfortable sharing that data.

About Professor Flanagan
Dr James Flanagan, completed his PhD in 2002 at the Queensland Institute of Medical Research in Brisbane, Australia, and has pursued postdoctoral work in Cancer Genetics, Epigenetics and Cancer Epigenetics. He was awarded a Breast Cancer Campaign Scientific Fellowship (Imperial, 2009-2014) and Senior Lecturer (2014-2019) and is now Reader in Epigenetics (2019-present) in the Division of Cancer, Dept. of Surgery and Cancer, Faculty of Medicine at Imperial College London.

He was awarded the British Association of Cancer Research Translational Researcher Award in 2011 and the prestigious DataIQ award in 2023 for his work using Shopping Loyalty Cards for early detection of ovarian cancer.

He is the principal investigator (PI) for the OCA funded programme “Risk and Prevention” and PI of the CRUK funded project “Cancer Loyalty Card Study (CLOCS)” In 2021 he was appointed as the Director of the MRes Cancer Biology.